High Yield Markets
  • World News
  • Politics
  • Investing
  • Stock
  • Editor’s Pick
Politics

JUST IN: Another Twitter Files Drop: How Pfizer Board Member Scott Gottlieb Used Twitter Lobbyist at White House to Suppress Debate on Covid Vaccines

by January 9, 2023
January 9, 2023

Journalist Alex Berenson released another ‘Twitter Files’ drop: How Scott Gottlieb – a top Pfizer board member – used the same Twitter lobbyist as the White House to suppress debate on Covid vaccines.

Including help from fellow head of the USDA!

Dr. Scott Gottlieb – former FDA Commissioner-turned-member-of-board-of-directors of Pfizer, pressured Twitter to censor former NY Times reporter and author Alex Berenson for questioning the mRNA vaccines.

Pfizer made billions of dollars off of its mRNA Covid vaccines.

1/ My first #TwitterFiles report: how @scottgottliebmd – a top Pfizer board member – used the same Twitter lobbyist as the White House to suppress debate on Covid vaccines, INCLUDING FROM A FELLOW HEAD OF @US_FDA!

Thanks @elonmusk for opening these files.https://t.co/UbHlmtjELP

— Alex Berenson (@AlexBerenson) January 9, 2023

2. In August 2021, Gottlieb told Todd O’Boyle – a senior manager in Twitter’s public policy department – that a tweet from Dr. Brett Giroir claiming CORRECTLY that natural immunity was superior to vaccine immunity was “corrosive” and might “go viral.”

2/ In August 2021, Gottlieb told Todd O’Boyle – a senior manager in Twitter’s public policy department – that a tweet from @drgiroir claiming CORRECTLY that natural immunity was superior to vaccine immunity was “corrosive” and might “go viral.”

— Alex Berenson (@AlexBerenson) January 9, 2023

3. Twitter put a misleading tag on the tweet, preventing it from being shared. Gottlieb then went after a tweet about Covid’s low risk to kids from Justin Hart. Pfizer would soon win the okay for its mRNA shots for children, so keeping parents scared was crucial…

3/ Twitter put a misleading tag on the tweet, preventing it from being shared. Gottlieb then went after a tweet about Covid’s low risk to kids from @justin_hart. Pfizer would soon win the okay for its mRNA shots for children, so keeping parents scared was crucial…

— Alex Berenson (@AlexBerenson) January 9, 2023

4. In October 2022, Scott Gottlieb claimed on Twitter and CNBC that he was not trying to suppress debate on mRNA jabs. These files prove that Gottlieb – board member at a company that has made $70 billion on the shots – did just that.

4/ In October 2022, @scottgottliebmd claimed on Twitter and CNBC that he was not trying to suppress debate on mRNA jabs. These files prove that Gottlieb – board member at a company that has made $70 billion on the shots – did just that.

Full story here:https://t.co/UbHlmtjELP

— Alex Berenson (@AlexBerenson) January 9, 2023

Excerpt from Alex Berenson’s Substack:

On August 27, 2021, Dr. Scott Gottlieb – a Pfizer director with over 550,000 Twitter followers – saw a tweet he didn’t like, a tweet that might hurt sales of Pfizer’s mRNA vaccines.

The tweet explained correctly that natural immunity after Covid infection was superior to vaccine protection. It called on the White House to “follow the science” and exempt people with natural immunity from upcoming vaccine mandates.

It came not from an “anti-vaxxer” like Robert F. Kennedy Jr., but from Dr. Brett Giroir, a physician who had briefly followed Gottlieb as the head of the Food & Drug Administration. Further, the tweet actually encouraged people who did not have natural immunity to “Get vaccinated!”

No matter.

By suggesting some people might not need Covid vaccinations, the tweet could raise questions about the shots. Besides being former FDA commissioner, a CNBC contributor, and a prominent voice on Covid public policy, Gottlieb was a senior board member at Pfizer, which depended on mRNA jabs for almost half its $81 billion in sales in 2021. Pfizer paid Gottlieb $365,000 for his work that year.

Gottlieb stepped in, emailing Todd O’Boyle, a top lobbyist in Twitter’s Washington office who was also Twitter’s point of contact with the White House.

The post was “corrosive,” Gottlieb wrote. He worried it would “end up going viral and driving news coverage.”

Read the full report here.

The post JUST IN: Another Twitter Files Drop: How Pfizer Board Member Scott Gottlieb Used Twitter Lobbyist at White House to Suppress Debate on Covid Vaccines appeared first on The Gateway Pundit.

previous post
“He Has My Forgiveness” – Rep. Matt Gaetz on Rep. Mike Rogers After Friday Night Rampage – Rogers Thankful and Regretful
next post
How 24-Yr-Old Damar Hamlin’s Collapse Brought America Together and Reminded Us of The Importance of Faith and Prayer [VIDEO]

You may also like

WHAT A JOKE: Chuck Schumer Claims Trump ‘is...

March 31, 2023

James Comey Fires Off Tweet Celebrating After Manhattan...

March 31, 2023

Republican Vivek Ramaswamy Slams ‘Dangerous’ Trump Indictment: ‘We...

March 31, 2023

“The Only Solution is to Shove it Down...

March 31, 2023

Michael Cohen Gets His Revenge! – Gloats After...

March 31, 2023

“Our Hearts Go Out to the Trans Community...

March 31, 2023

Mike Pence Calls Indictment of President Trump an...

March 31, 2023

“I’m Petrified for My Country – This Is...

March 31, 2023

Pelosi Statement on Trump Indictment Turns Justice on...

March 31, 2023

REPORT: CBS News Executives Barred the Word ‘Transgender’...

March 31, 2023
Join The Exclusive Subscription Today And Get Premium Articles For Free


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

  • The New Deal and Recovery, Part 27: Deposit Insurance

    March 28, 2023
  • The New Deal and Recovery, Part 26: The RFC, Conclusion

    March 24, 2023
  • The New Deal and Recovery, Part 25: The RFC, Continued

    March 20, 2023
  • The New Deal and Recovery, Part 24: The RFC

    March 14, 2023
  • The New Deal and Recovery, Part 23: The Great Rapprochement

    February 7, 2023
  • About Us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Copyright © 2023 HighYieldMarkets.com All Rights Reserved.

High Yield Markets
  • World News
  • Politics
  • Investing
  • Stock
  • Editor’s Pick